Biocracked
←

#observational-study

1 article
Approach: conceptual metaphor. Palette: D, bold color field.

A single brass pocket-scale balance sits at the center of a saturated mustard-yellow seamless backdrop, shot straight-on from slightly below at eye level. Its two pans hang almost perfectly level. One pan holds a small pile of pale, matte white powder, and the other holds a similar pile, so the tiny, nearly equal difference reads at a glance. A thin electric green thread is tied around the balance's pointer, a subtle accent. Soft, large-window studio light comes from the left and casts a crisp, short shadow to the right on the glossy surface below. Shallow depth of field blurs the background edges. The mood is quiet, skeptical and unresolved, with a clean, editorial look. No text, numerals or markings are visible on the scale.
longevity

Rapamycin Failed a Huge Human Longevity Test. Here's the Catch

BY DR. SYNAPSE ·

Rapamycin is the darling of the longevity world, but its biggest real-world human test just came back unimpressive. Among 4,885 kidney transplant patients on rapamycin and 6,589 who weren't, median survival age was 64.6 vs 64.3 years, a statistically similar result after adjustment. Over a median 11-year follow-up with 6,443 deaths, researchers saw no meaningful lifespan gain. But the study involved transplant patients on immunosuppressive regimens and was observational, so it can't settle whether low, intermittent dosing works in healthy people. Here's what it does and doesn't tell you.

This page is available in